Status: current, Primitive. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4551651000168110 | Tobramycin PF (Pfizer) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4551661000168112 | Tobramycin PF (Pfizer) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tobramycin PF (Pfizer) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tobramycin PF (Pfizer) 80 mg/2 mL injection, 5 x 2 mL ampoules | has TP | True | Tobramycin PF (Pfizer) | Inferred relationship | Some | |
| Tobramycin PF (Pfizer) 80 mg/2 mL injection, 2 mL ampoule | Is a | True | Tobramycin PF (Pfizer) | Inferred relationship | Some | |
| Tobramycin PF (Pfizer) 80 mg/2 mL injection, 5 x 2 mL ampoules | has TP | True | Tobramycin PF (Pfizer) | Inferred relationship | Some |
Reference Sets
FHIR